Crystallization of Cyclophosphamide Monohydrate During Lyophilization

The purpose of this study was to investigate the phase behavior of cyclophosphamide (CPA) during various stages of lyophilization, with special emphasis on obtaining crystalline CPA monohydrate (CPA-MH) in the lyophilized product. Subambient differential scanning calorimetry and low-temperature X-ray diffractometry (LTXRD) were used to study the phase behavior of CPA solution (3.7% w/v). In situ lyophilization in LTXRD chamber was used to monitor the phase transitions occurring during the drying stages. Finally, the implications of these findings were confirmed by freeze-drying the aqueous solution in a laboratory-scale freeze-dryer. The results suggested that CPA remains amorphous during freeze concentration, with a T_g' of ?50°C. However, its crystallization as CPA-MH can be induced by annealing the frozen solution between ?5°C and ?10°C. In situ lyophilization in LTXRD showed that the CPA-MH crystallized during annealing, rapidly dehydrated during primary drying, thereby causing structural collapse. The dehydration of CPA-MH can be prevented by lowering the escaping tendency of water molecules from the crystal lattice of CPA-MH by maintaining the chamber pressure to 300, 400, or 500 mTorr. This study highlights the relationship of process parameters used during lyophilization with the solid form of lyophilized CPA.     

在线成像结合红外光谱技术对头孢克肟反应结晶过程的工艺优化

头孢克肟的粒度分布、结晶度及杂质含量是影响其加工性能、颜色 ( 白度 )、贮存时间和生物毒性的关键质量指标, 在实际生产过程中发现这些关键指标较难控制。本研究应用了先进在线过程分析技术对头孢克肟的反应结晶过程进行了测量和 分析,包括：傅里叶变换衰减全反射红外光谱仪 (ATR-FTIR) 准确测量结晶过程浓度,并辅助解释反应结晶过程转晶机理,在 线成像系统测量结晶过程颗粒的形貌和粒形变化,在线浊度仪测量成核时刻。实验考察了反应结晶过程的反应温度、养晶时刻、 养晶时间、加料速率、搅拌速率等工艺条件对头孢克肟粒度分布、白度、结晶度和杂质含量的影响,探寻反应结晶过程晶型转 变的规律。结果表明,头孢克肟结晶为聚结生长方式,养晶时刻是影响其聚集体粒度分布及白度的关键因素,养晶时间与滴酸 速率是影响结晶度的关键因素。实验优化得到了头孢克肟反应结晶的最佳操作工艺并可为其工业化提供重要参考,利用该工艺 得到了粒度分布均匀、结晶度高、杂质含量低和白度好的产品。     

Influence of Glass Forming Ability on the Physical Stability of Supersaturated Amorphous Solid Dispersions

In this study, the influence of the glass-forming ability (GFA) of a drug on its physical stability in a supersaturated solid dispersion was investigated. Nine drugs were classified according to their GFA using their respective critical cooling rate. Their respective solubility in poly(vinylpyrrolidone-co-vinyl acetate) 6:4 (PVPVA64) was predicted using the melting point depression method based on the Flory-Huggins lattice theory. Supersaturated amorphous solid dispersions at a level of 25% w/w drug above saturation solubility in the polymer were prepared by film-casting, and their respective physical stability at temperatures of 10°C or 20°C above or below their respective T_g (dry conditions) was monitored by the use of polarized light microscopy. This study showed that drugs with good GFA (class 3) on average have higher physical stability in supersaturated amorphous solid dispersion compared to drug with modest GFA (class 2), which in turn have higher physical stability in supersaturated amorphous solid dispersion than drugs with poor GFA (class 1). These results indicate that the GFA of a drug and its physical stability in a supersaturated amorphous solid dispersion stored at a temperature above or below its T_g are correlated.     

高纯度庆大霉素C1a游离碱制备工艺研究

目的 探索用大孔吸附树脂层析法及盐析结晶法精制纯化硫酸依替米星起始物料-庆大霉素C1a成品(HPLC纯度91%~93%),从而减少由起始物料引入依替米星杂质的水平。方法 以庆大霉素C1a吸附量和庆大霉素C1a纯度为指标,考察大孔吸附树脂纯化庆大霉素C1a的吸附性能和洗脱参数;以盐析后庆大霉素C1a样品纯度和盐析收率为指标,考察盐析工艺最佳温度、溶剂、酸的添加量及酸的种类。结果 获得较优的树脂NM200,获得较优的解析液pH值为2.0和流速0.5BV/h。经过优化后,纯化收率从65%提高至74%。通过盐析结晶条件筛选和优化,确定室温先加溶剂后加硫酸(pH6.5)和甲醇与乙醇1:2的条件较优,优化后获得的庆大霉素C1a纯度达到98.2%,收率大于93%。研究了多种无机酸盐析结晶的情况,发现磷酸、硫酸和碳酸条件下能析出白色固体。结论 通过比较大孔吸附树脂和盐析结晶的纯化连接,组合纯化后获得的庆大霉素C1a游离碱纯度大于99.0%,比纯化前样品提高6%以上,收率大于70%。     

Influence of polymorphism on the surface energetics of salmeterol xinafoate crystallized from supercritical fluids

Purpose. To characterize the surface thermodynamic properties of two polymorphic forms (I and II) of salmeterol xinafoate (SX) prepared from supercritical fluids and a commercial micronized SX (form I) sample (MSX). Methods. Inverse gas chromatographic analysis was conducted on the SX samples at 30, 40, 50, and 60°C using the following probes at infinite dilution: nonpolar probes (NPs; alkane C5-C9 series); and polar probes (PPs; i.e., dichloromethane, chloroform, acetone, ethyl acetate, diethyl ether, and tetrahydrofuran). Surface thermodynamic parameters of adsorption and Hansen solubility parameters were calculated from the retention times of the probes. Results. The free energies of adsorption (-G_A) of the three samples obtained at various temperatures follow this order: SX-II > MSX SX-I for the NPs; and SX-II > MSX > SX-I for the PPs. For both NPs and PPs, SX-II exhibits a less negative enthalpy of adsorption (H_A) and a much less negative entropy of adsorption (S_A) than MSX and SX-I, suggesting that the high -G_A of SX-II is contributed by a considerably reduced entropy loss. The dispersive component of surface free energy (_s ^D) is the highest for MSX but the lowest for SX-II at all temperatures studied, whereas the specific component of surface free energy of adsorption (-G_A ^SP) is higher for SX-II than for SX-I. That SX-II displays the highest -G_A for the NP but the lowest _s ^D of all the SX samples may be explained by the additional -G_A change associated with an increased mobility of the probe molecules on the less stable and more disordered SX-II surface. The acid and base parameters, K_A and K_D, that were derived from H_A ^SP reveal significant differences in the relative acid and base properties among the samples. The calculated Hansen solubility parameters (_D, _P, and _H) indicate that the surface of SX-II is the most polar and most energetic of all the three samples in terms of specific interactions (mostly hydrogen bonding). Conclusions. The metastable SX-II polymorph possesses a higher surface free energy, higher surface entropy, and a more polar surface than the stable SX-I polymorph.     

Dissolution Rate Enhancement by in Situ Micronization of Poorly Water-Soluble Drugs

Purpose. The purpose of this study was to evaluate a novel in situ micronization method avoiding any milling techniques to produce nano- or microsized drug particles by controlled crystallization to enhance the dissolution rate of poorly water-soluble drugs. Methods. Ibuprofen, itraconazole, and ketoconazole microcrystals were prepared by the association of the previously molecularly dispersed drug using a rapid solvent change process. The drug was precipitated in the presence of stabilizing agents, such as hydrocolloids. The obtained dispersion was spray-dried. Particle size, morphology, dissolution rate, specific surface area, and wettability were analyzed. Physicochemical properties were characterized using differential scanning calorimetry and X-ray diffractometry. Results. The obtained dispersions showed a homogeneous particle size distribution. Drugs are obtained in a mean particle size of approximately 2 m and below. A high specific surface area was created and in situ stabilized. Different stabilizers showed differences in protecting the precipitated drug from crystal growth. The surface was hydrophilized because of the adsorbed stabilizer. Thus, a drug powder with markedly enhanced dissolution rate was obtained. Conclusions. In situ micronization is a suitable method for the production of micro-sized drugs. This technique can be performed continuously or discontinuously and uses only common technical equipment. Compared to milled products drug properties are optimized as all particle surfaces are naturally grown, the particle size is more uniformly distributed and the powder is less cohesive.     

3-乙酰硫基-2-甲基丙酰基-L-脯氨酸的结晶体拆分工艺改进

目的　提高D - 3-乙酰硫基 - 2 -甲基丙酰基 -L -脯氨酸的质量和收率。方法　考察了不同结晶工艺水添加量,溶液pH值,温度及搅拌速度对D - 3-乙酰硫基 - 2 -甲基丙酰基 -L -脯氨酸收率和质量的影响。结果　新工艺在产品质量和收率方面均优于老工艺。结论　新工艺操作简便易行,稳定性好。     

Identification of Physical-Chemical Variables Affecting Particle Size Following Precipitation Using a Supercritical Fluid

The physical-chemical processing variables affecting particle size following precipitation using the supercritical antisolvent (SAS) method were investigated by varying both the composition of the feed solvent and the structure of the solute, using a series of steroids. The key factor influencing particle size in these studies appears to be the solubility of the drug in the organic solvent/supercritical fluid mixture, where relatively high solubility causes a lower degree of supersaturation in the precipitation vessel, resulting in a relatively large particle size. Higher operating pressures result in larger particle sizes, probably through the effect of pressure on solubility. Physical properties of the carrier solvent, such as vapor pressure and dielectric constant, were not effective predictors of relative particle size of the precipitated powder, nor was solubility of the model drug in the carrier solvent. In limited studies of the physical state of the precipitated solid, higher apparent crystallinity was observed for powders with larger particle size. A precipitate of a different crystal form was observed when starting with hydrocortisone hemisuccinate monohydrate and may represent the loss of water of hydration. An amorphous solid was precipitated when starting with yttrium acetate dihydrate. Broad guidelines for effective particle size reduction using this technique are presented.     

尿沉渣分析仪在预防泌尿系统结石中的作用

[目的]探讨UF-100i尿沉渣分析仪在预防及诊断泥沙样泌尿系统结石中的作用。[方法]对因食用三聚氰胺污染奶粉来我院就诊的2787例儿童,分别应用UF-100i尿沉渣分析仪筛查尿结晶,彩色多普勒超声仪筛查泌尿系统结石或结晶,并对两种方法的检查结果进行比较。[结果]尿结晶占18%,超声诊断结石和结晶占4%。两者相比差异有统计学意义(P﹤0.05);超声诊断结石和结晶与尿结晶符合率随着尿结晶量增加而明显增高,尤其尿结晶值在大于220/μl时,符合率达83%,趋势χ2检验P﹤0.005。[结论]尿沉渣分析仪可为泌尿系统结石的早期发现及预防提供重要依据。     

Predictions of Onset of Crystallization from Experimental Relaxation Times I-Correlation of Molecular Mobility from Temperatures Above the Glass Transition to Temperatures Below the Glass Transition

Purpose Predicting onsets of crystallization at temperatures below T _g, from data above T _g, would require that the correlation between crystallization onset and mobility is same above and below T _g, and the techniques being used to measure mobility above and below T _g are measuring essentially the same kind of mobility. The aim of this work is to determine if the relaxation times obtained using different techniques (DSC, TAM) below T _g correlate with relaxation time obtained above T _g using dielectric spectroscopy.Methods Model compounds for this work were chosen based on their varied ΔH _f, ΔC _p(T _g) and H-bonding in crystalline state vs. amorphous state. Relaxation times above T _g were determined by the simultaneous fit of real and imaginary permittivity to the Cole-Davidson model. Tau and beta below T _g were determined using isothermal microcalorimetry (TAM) or MDSC. MDSC was used to calculate Kauzmann temperature and strength of the glass using established relationships.Results Indomethacin, nifedipine and flopropione showed Arrhenius temperature dependence throughout the entire temperature range and extrapolation of τ ^β measured above T _g by dielectric relaxation agreed with τ ^β measured below T _g by TAM/MDSC. Ketoconazole, however, showed the expected VTF behavior. For at least two compounds compared (indomethacin and ketoconazole), relaxation times measured by TAM and MDSC did not agree, with TAM giving significantly lower values of τ ^β , but TAM and MDSC relaxation times appeared to extrapolate to a common value at T _g.Conclusions It was found that, for all cases studied, relaxation time constants determined above and below T _g did appear to extrapolate to the same value around T _g indicating that molecular mobility measured above and below T _g using different techniques is highly correlated.